Nalaganje...

Immune Checkpoint Inhibitors in NSCLC

Lung cancer is the leading cause of cancer-related mortality worldwide. Cytotoxic chemotherapy and tyrosine kinase inhibitors provide palliation and prolong survival, however, the median survival for patients with metastatic disease remains poor and more effective therapies are needed. Immune checkp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Johnson, Douglas B., Rioth, Matthew J., Horn, Leora
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216599/
https://ncbi.nlm.nih.gov/pubmed/25096781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-014-0305-5
Oznake: Označite
Brez oznak, prvi označite!